CXCL12 and neoplasm: OPN could facilitate the transformation of mesenchymal stromal cells into CAFs, as well as increasing levels of CAF markers such as α-SMA, CXCL12, FSP-1, and tenascin-c specifically at tumor metastatic sites (88).